Reply to Aubry and Veziris: Smear Microscopy Complements Xpert MTB/RIF When Considering Nontuberculous Mycobacterial Infections
Open Access
- 15 October 2019
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (8) , 1073-1074
Abstract
No abstract availableKeywords
Funding Information
- Chonnam National University Hospital Biomedical Research Institute (BCRI19024)
This publication has 6 references indexed in Scilit:
- Xpert MTB/RIF Assay as a Substitute for Smear Microscopy in an Intermediate-Burden SettingAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Treatment ofMycobacterium aviumComplex Pulmonary DiseaseTuberculosis and Respiratory Diseases, 2019
- Treatment of Non-Tuberculous Mycobacterial Lung DiseaseCurrent Treatment Options in Infectious Diseases, 2016
- Multicenter Evaluation of Anyplex Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary SpecimensJournal of Clinical Microbiology, 2016
- Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatmentThe Lancet Respiratory Medicine, 2013
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007